RxDoctor Payments Data

Michael Bublik, MD

Facial Plastic Surgery · Glendale, CANPI 1679784664

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,714 of the $4,673 with a category attached, or 79.5%. 12 manufacturers reported payments, led by Stryker at 36.9% of the total. Reporting peaked in 2022 at $1,661 and has fallen 85.9% since, to $235 in 2025.

$4,673in general payments, 2019–2025

Across 74 payments — averaging $63.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Medtronic$2K
  • Watermark Medical, Inc.$301
  • Aerin Medical Inc.$182
  • Intersect ENT, Inc.$177
  • Acclarent, Inc$174
  • plus $509 from 6 others

What the payments were for

  • Travel & lodging$95921%
  • Food & beverage$3,71479%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker37$1,725
Medtronic(2 entities)7$1,604
Watermark Medical, Inc.1$301
Aerin Medical Inc.2$182
Intersect ENT, Inc.2$177
Acclarent, Inc3$174
Galderma Laboratories, L.p.7$141
Optinose US, Inc.7$120
Carestream Dental, LLC2$83
Regeneron Healthcare Solutions, Inc.2$80
Merz North America, Inc.2$46
Jubilant Hollisterstier LLC2$38

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,673 in reported general payments places this provider in the 80th percentile of 120 facial plastic surgery providers in California.

See all facial plastic surgery providers in California

Medicare billing

Part B allowed, 2024
$1,415,385
Medicare patients
1,574
Services billed
21,649

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl1,015$18,674
Fluticasone Propionate1,781$14,098
Ipratropium Bromide511$13,429
Mometasone Furoate803$12,533
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth60$7,635
Epinephrine16$3,488
Azelastine-FluticasoneAzelastine/Fluticasone28$2,712
Ofloxacin136$2,478
Olopatadine Hcl29$2,353
Montelukast Sodium369$1,898
Diclofenac Sodium36$1,161
Omeprazole377$1,140
Albuterol Sulfate HfaAlbuterol Sulfate33$1,017
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc15$1,014
Famotidine399$974

Paid to pharmacies, not to this prescriber.

Other facial plastic surgery in Glendale

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →